IntrinsicIntrinsic
← Scroll for more →

Financial Statements — GANX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents13.0816.5420.848.816.699.0710.3912.0516.9410.6411.794.276.325.997.3110.8814.3134.3436.8840.98
Short-term Investments------------------2.025.007.969.8711.8312.8311.859.94------
Accounts Receivable------------------------------------0.010.02
Total Current Assets14.9718.2222.2410.529.3111.1511.6013.7418.5413.8617.7813.2417.3119.3221.0924.3525.8336.3937.7241.55
Property, Plant & Equipment0.050.050.070.090.100.100.100.120.120.110.130.130.140.140.140.140.140.110.110.10
Total Non-current Assets0.450.520.580.450.530.470.520.620.660.710.830.860.952.003.013.986.061.211.261.01
Total Assets15.4218.7422.8210.979.8311.6212.1214.3719.2014.5818.6114.1018.2621.3224.1028.3331.8937.6038.9942.56
Accounts Payable1.221.520.831.582.712.150.951.102.051.411.321.380.922.211.631.020.952.120.560.79
Total Current Liabilities3.433.893.354.175.205.033.914.596.525.004.955.765.595.154.134.333.414.222.553.58
Long-term Debt0.340.370.400.420.450.430.440.490.490.510.570.540.580.590.600.590.630.650.690.62
Total Non-current Liabilities0.700.840.900.890.940.820.870.860.890.931.081.001.581.031.091.331.461.551.611.44
Total Liabilities*4.134.734.255.066.145.844.785.467.415.946.036.777.176.185.225.664.875.774.175.02
Retained Earnings(111.64)(101.36)(81.19)(81.19)(81.19)(81.19)(60.78)(60.78)(60.78)(60.78)(38.52)----(38.52)(20.93)(20.93)(20.93)(20.93)(7.03)(7.03)
Total Stockholder Equity11.2914.0118.565.913.705.787.348.9111.788.6412.587.3311.0915.1418.8822.6627.0231.8334.8237.55
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue--------------------0.000.000.000.060.000.000.100.040.040.02
Research & Development2.142.762.352.852.762.261.222.624.442.512.372.373.992.792.271.962.581.561.472.48
Selling, General & Admin2.542.592.121.942.332.112.111.843.751.872.032.523.742.492.292.792.691.781.782.19
Total Operating Expenses4.685.354.474.795.094.373.334.468.184.384.414.897.735.284.564.755.273.333.254.66
Operating Income(4.68)(5.35)(4.47)(4.79)(5.09)(4.37)(3.33)(4.46)(8.18)(4.38)(4.41)(4.89)(7.73)(5.23)(4.56)(4.75)(5.18)(3.29)(3.21)(4.64)
Pretax Income(4.57)(5.43)(4.47)(4.74)(5.67)(4.43)(3.26)(4.47)(8.14)(3.99)(4.71)(4.70)(7.66)(5.12)(4.60)(4.55)(5.08)(3.27)(3.23)(4.66)
Tax Provision0.100.180.070.550.140.100.500.010.000.020.010.020.030.020.080.000.010.00(0.01)0.01
Net Income(4.68)(5.61)(4.54)(5.28)(5.81)(4.53)(3.77)(4.49)(8.14)(4.01)(4.72)(4.72)(7.69)(5.14)(4.67)(4.56)(5.09)(3.27)(3.22)(4.66)
Basic EPS(0.11)(0.13)(0.11)(0.15)(0.19)(0.16)(0.08)(0.17)(0.42)(0.22)(0.29)(0.37)(0.62)(0.43)(0.39)(0.38)(0.43)(0.28)(0.26)(0.39)
Diluted EPS(0.11)(0.13)(0.11)(0.15)(0.19)(0.16)(0.08)(0.17)(0.42)(0.22)(0.29)(0.37)(0.62)(0.43)(0.39)(0.38)(0.43)(0.28)(0.26)(0.39)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(4.68)(4.73)(4.62)(4.93)(5.10)(3.82)(3.45)(6.08)(5.76)(3.59)(5.66)(3.97)(5.02)(4.22)(3.90)(3.29)(5.05)(2.45)(4.15)(2.19)
Capital Expenditures------------0.000.000.02--0.000.000.000.01--0.060.040.010.010.03
Free Cash Flow*------------(3.46)(6.08)(5.78)--(5.66)(3.97)(5.03)(4.23)--(3.35)(5.10)(2.46)(4.16)(2.22)
Investing Cash Flow------------(0.04)-0.002.003.023.141.933.052.110.13(0.01)(14.89)(0.01)(0.01)(0.03)
Financing Cash Flow1.370.4016.557.032.472.402.310.8110.04(0.15)9.560.132.200.75(0.02)(0.02)0.00(0.04)(0.01)0.00
← Scroll for more columns →

* Derived from reported values